Condition: Heart Failure · Sponsor: Tor Biering-Sørensen
The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.
This description comes directly from the study's public registry record.
Niklas Dyrby Johansen, MD · +4520204794 · niklas.dyrby.johansen@regionh.dk
Marie Terese Barlebo Madsen, PhD · +4553377345 · marie.terese.barlebo.madsen@regionh.dk
Always discuss trial participation with your own doctor first.
| Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte | Hellerup, Capital Region, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06099158